Press Releases

NASHVILLE, Tenn. , Sept. 27, 2018 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) , a U.S. specialty pharmaceutical company and Clinigen Group plc (AIM: CLIN, ' Clinigen ') , the global pharmaceutical and services company, announce a new publication in Lung Cancer: Targets and

Former Chairman of Sony Music Nashville NASHVILLE, Tenn. , Sept. 24, 2018 /PRNewswire/ --   Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) is pleased to announced that Joe Galante , music industry executive, has joined its Board of Directors. He is the former Chairman of Sony Music in Nashville and

17% Revenue Growth Over Prior Year Period NASHVILLE, Tenn. , Aug. 14, 2018 /PRNewswire/ --  Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care, gastroenterology, and oncology supportive care today announced second quarter 2018 financial

Biopharmaceutical Veteran Appointed as Director of Clinical and Regulatory Affairs NASHVILLE, Tenn. , Aug. 13, 2018 /PRNewswire/ --  Cumberland Pharmaceuticals (NASDAQ: CPIX) today announced the appointment of biopharmaceutical industry veteran Adam Haeberle , Ph.D.

NASHVILLE, Tenn. , Aug. 7, 2018 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release second quarter 2018 financial results after the market closes on Tuesday, August 14 , 2018.  A conference call and live Internet webcast will be held on Tuesday,

NEW ORLEANS, LA and NASHVILLE, TN. (June 5, 2018) – LSU Health New Orleans and Cumberland Emerging Technologies Inc. (CET) have entered into a collaboration agreement to develop new biomedical products

- Caldolor® sNDA accepted by the FDA
- Advancing four Phase II clinical programs

       Pharmaceutical veteran to lead Cumberland's Hospital Sales Force   NASHVILLE, Tenn., May 07, 2018 – Cumberland Pharmaceuticals – today announced the appointment of pharmaceutical industry veteran Chris Bitterman as Cumberland's Hospital Sales Director.

NASHVILLE, Tenn. , May 1, 2018 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release first quarter 2018 financial results after the market closes on Tuesday, May 8, 2018 .  A conference call and live Internet webcast will be held on Tuesday, May 8, 2018